Description de l'entreprise
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.
Conseil d'administration & Conseil de surveillance
| PDG |
| Robert B. Ford, Daniel Salvadori |
| Conseil d'administration |
| Robert E. Funck, Jr., Hubert L. Allen, John M. Capek, Lisa D. Earnhardt, John F. Ginascol, Joseph Manning, Mary K. Moreland, Andrea Wainer, Gregory A. Ahlberg, Christopher J. Calamari, Michael D. Dale, J. Scott House, Sammy Karam, Fernando Mateus, Louis H. Morrone, Michael J. Pederson, Julie L. Tyler, Jared L. Watkin, Alejandro D. Wellisch, Randel W. Woodgrift |
| Conseil de surveillance |
| Robert B. Ford, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, John G. Stratton, Michael F. Roman, Michelle A. Kumbier, Nancy McKinstry, Robert J. Alpern, Claire Babineaux-Fontenot, William A. Osborn, Glenn F. Tilton, Paola Gonzalez |
Données de l'entreprise
| Nom: |
Abbott Laboratories |
| Adresse: |
100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA |
| Téléphone: |
+1-224-667-6100 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.abbott.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
87.10% |
| IPO date: |
01/06/1972 |
Relations avec les investisseurs
| Nom: |
Scott Leinenweber |
| Téléphone IR: |
+1-224-667-8945 |
| IR-Fax: |
- |
| E-mail IR: |
-
|
